Amneal to acquire Actavis Australia’s generics business

MELBOURNE and SYDNEY, Australia — Amneal Pharmaceuticals Pty will acquire Actavis Australia Pty’s generic pharmaceutical business, the companies announced. Financial terms of the agreement are not available at this time, though both sides said they would work quickly in order to avoid disruption of supply to those who purchase Actavis’ products.

 

Actavis will continue to promote and distribute such branded products as Actonel and Oxytrol. Additionally, Actavis will also continue to supply Botox, eye-care products and all other heritage Allergan products, the company said.